1)Heathcote EJ, et al:Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. N Engl J Med 343:1673-1680, 2000
2)Bruno S, et al:Efficacy and safety of peginterferon alfa-2a(40KD)plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis. Hepatology 51:388-397, 2010
3)泉 並木,他:C型代償性肝硬変に対するペグインターフェロンa-2a(40KD)とリバビリン併用療法の有効性および安全性の検討―臨床第Ⅱ/Ⅲ相試験.消化器内科 53:335-342, 2011
4)Di Bisceglie AM, et al:Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. N Engl J Med 359:2429-2441, 2008
5)Lok AS, et al:Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C. Gastroenterology 140:840-849, 2011
6)Bruix J, et al:Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C. Gastroenterology 140:1990-1999, 2011